The Globe® mapping and ablation system
Kardium® is developing a ground-breaking medical device, the Globe® mapping and ablation system, for the diagnosis and treatment of atrial fibrillation.
Atrial fibrillation is the most common heart rhythm disorder, affecting more than 34 million people worldwide¹.
The Globe system is the most complete solution for the treatment of atrial fibrillation.
The safety and effectiveness of the Globe system are still under investigation. The Globe system has not received market approval, licencing, or clearance, and it is currently not available for sale in any jurisdictions. CAUTION: Investigational device limited by federal (or United States) law to investigational use.
¹ Chugh, et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2014